Fenaton

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fenaton

Property Description
Active Ingredient Mefenamic Acid (INN)
Form Capsule, Tablet
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
General Purpose Analgesic, Anti-inflammatory, Antipyretic
Origin Synthetic organic compound

What Type of Medicine is Fenaton, and What is its Composition?

Fenaton is a pharmaceutical preparation classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), whose therapeutic effects are derived solely from its active ingredient, Mefenamic Acid. The core compound, Mefenamic Acid (INN), is a synthetic organic compound belonging specifically to the Fenamate subgroup, differentiating it chemically from other NSAIDs. Mefenamic acid acts as a general-purpose analgesic and anti-inflammatory agent. This formulation is a single-ingredient product intended for oral administration, typically available in solid dosage forms such as a capsule or a tablet, which consist of the active agent combined with necessary pharmaceutical excipients.


What is the General Therapeutic Purpose of Mefenamic Acid?

The general therapeutic purpose of Mefenamic Acid is to provide simultaneous analgesic, anti-inflammatory, and antipyretic effects by blocking the synthesis of chemical messengers in the body. The fundamental function of this NSAID is achieved through inhibiting the cyclooxygenase (COX) enzymes, which are essential for producing prostaglandins. This mechanism is effective in moderating pain and inflammation signals at their source. The medicine works by interrupting the body’s pain and swelling signals rather than simply masking them. Mefenamic Acid is often utilized in scenarios requiring relief from acute pain and associated inflammation. By interrupting this process, Fenaton helps diminish discomfort, reduce swelling, and lower an elevated body temperature.

Regulatory References

  1. Mefenamic Acid (DailyMed)

What side effects are possible with Fenaton?

Possible Side Effects and Safety Information: Fenaton

The official safety information for Fenaton includes a Boxed Warning regarding the risk of serious and potentially fatal cardiovascular and gastrointestinal events. These serious adverse reactions include myocardial infarction (MI) and stroke, which may occur early in treatment, and serious gastrointestinal inflammation, bleeding, ulceration, and perforation. The risk of these events may increase with longer duration of use or higher doses.

Adverse Reaction Profile

Adverse reactions span several system-organ classes. Common reactions (reported in ge 5% of patients) typically involve the gastrointestinal and nervous systems, including dyspepsia, headache, dizziness, and somnolence.

Serious Safety Considerations

Beyond cardiovascular and GI risks, other serious adverse reactions documented in regulatory labeling include:

  • Hepatotoxicity: Liver injury, sometimes fatal.
  • Renal Toxicity: Risk of new onset or worsening renal impairment, including hyperkalemia. Use is generally avoided in advanced renal disease.
  • Hypersensitivity Reactions: Potential for severe, sometimes fatal, anaphylactic reactions and serious skin reactions, such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
  • Hematologic Toxicity: Risk of hematologic abnormalities (e.g., anemia).

Safety Restrictions and Specific Populations

Fenaton is contraindicated in patients with a known hypersensitivity to the drug, a history of asthma, urticaria, or allergic-type reactions after taking aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs), or previous serious skin reactions to NSAIDs.

In pregnancy, use should be avoided at or after 30 weeks of gestation due to the risk of premature closure of the fetal ductus arteriosus and fetal renal dysfunction. Geriatric patients may be at greater risk for serious adverse effects, consistent with the overall safety profile of the NSAID class.

Overdose and Emergency Response

Overdose and When to Seek Help

Fenaton is associated with a risk of acute overdosage, which is a medical emergency. The clinical manifestations of an overdose primarily affect the central nervous system and the gastrointestinal tract, ranging from mild to severe presentations.

System Documented Overdose Symptoms
Gastrointestinal Headache, nausea, vomiting, epigastric pain, and gastrointestinal bleeding. Diarrhea has also been reported.
Central Nervous System Drowsiness, disorientation, excitation, tinnitus, fainting, convulsions, and coma (rarely).

When to Seek Immediate Medical Attention

Acute overdosage symptoms, especially severe manifestations like gastrointestinal bleeding, convulsions, or loss of consciousness, require immediate professional medical intervention.

Regulatory documents emphasize that the management of an acute overdose should be symptomatic and supportive treatment. Specifically, procedural instructions include the immediate emptying of the stomach by inducing emesis or through gastric lavage, followed by the administration of activated charcoal to limit further absorption of the substance. These steps are critical and are defined for managing the exposure risk associated with acute overdosage.

Therapeutic Uses of Fenaton

Fenaton is commonly used to help with symptoms related to physical discomfort, inflammation, and specific gynecological conditions. This NSAID is used for the relief of mild to moderate pain and the treatment of primary dysmenorrhea.


Supportive Management for Menstrual Pain and Menorrhagia

Fenaton is commonly used across conditions characterized by episodic symptom patterns, particularly to address painful uterine cramps (primary dysmenorrhea) and may assist with the management of excessive blood loss associated with heavy periods (menorrhagia). This therapeutic support helps ease the overall symptom burden during the monthly cycle, and may contribute to improved day-to-day comfort when symptoms intensify. The medication is generally applied in addressing symptoms of acute pain, joint pain associated with arthritis, and fever.

“It is commonly used when short-term symptomatic assistance is needed to address discomfort and inflammation.”

Relief for Acute Pain, Inflammation, and Fever

This medication is considered relevant for easing symptoms in a spectrum of acute, short-term situations. It is applied across domains where short-term symptomatic assistance is needed, such as managing mild to moderate acute pain (including muscular, traumatic, and dental discomfort) alongside localized inflammation and swelling. Furthermore, it is relevant for temporary assistance in symptom stabilization by helping to reduce elevated body temperature (fever). Fenaton is also used for supportive therapeutic benefit for adults with rheumatoid arthritis and osteoarthritis, and may assist with easing joint pain and stiffness during symptomatic flares.

Quick Fact: Relief for Acute Discomfort Fenaton is often used when symptoms intensify and supportive relief is needed, particularly for acute pain and inflammation.

Regulatory References

  1. NIH DailyMed label for Mefenamic Acid

Eligibility and Restrictions for Use

Fenaton is an NSAID with strict regulatory guidelines defining eligible populations. Use is contraindicated (absolutely prohibited) in individuals with known hypersensitivity to the medicine, aspirin, or other NSAIDs, or a history of recurrent gastrointestinal ulceration, bleeding, or perforation.

Contraindications and Restrictions

Population Group Eligibility Status (Regulatory Wording)
Severe Organ Impairment Contraindicated in severe heart failure, severe renal failure, and severe hepatic failure.
Cardiovascular Procedures Contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Pregnancy Contraindicated during the last trimester of pregnancy (prohibited at or after 30 weeks gestation).
Pediatric Use Use is not established in children younger than 14 years of age (US FDA); not recommended in younger children.
Fertility Not recommended for women attempting to conceive, as use may impair female fertility.

Populations with non-severe organ or cardiac impairment, the elderly, and those with certain risk factors require limited use at the lowest effective dose for the shortest duration.

What should I know about interactions with other medicines?

Fenaton Interactions with other medicines and products

The regulatory documentation for Fenaton (Mefenamic Acid) defines specific interaction patterns primarily related to pharmacokinetic modification and pharmacodynamic risk reinforcement. Co-administration with other non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs) must be avoided due to the documented increase in the risk of serious gastrointestinal adverse events. Fenaton is formally contraindicated for use in the peri-operative setting of Coronary Artery Bypass Graft (CABG) surgery.

A significant interaction domain involves pharmacodynamic reinforcement with substances that increase bleeding risk, including oral anticoagulants like Warfarin, corticosteroids, and Selective Serotonin Reuptake Inhibitors (SSRIs). Furthermore, Fenaton is documented to interfere with the anti-platelet effect of low-dose Aspirin. Other interactions reduce the efficacy of co-administered treatments, such as antihypertensives and diuretics.

Regarding pharmacokinetic modification, Mefenamic Acid is predominantly metabolized by CYP2C9. Co-administration with Lithium and Methotrexate is documented to increase the plasma concentration of these agents by reducing their renal clearance. Separately, antacids containing Magnesium Hydroxide are stated to significantly increase the absorption of Fenaton. Finally, alcohol ingestion increases the risk of developing gastrointestinal complications, and elderly patients and those with impaired renal function are identified as being at increased risk for renal deterioration when co-administered with ACE Inhibitors or Angiotensin II Antagonists.

Mechanism of Action

Fenaton exerts its effect primarily by acting as a non-selective competitive inhibitor of the Cyclooxygenase (COX) enzymes, targeting both COX-1 and COX-2. This molecular interaction blocks the enzymatic conversion of arachidonic acid, leading to a significant reduction in the cellular synthesis of prostaglandins, which function as key local chemical mediators.


The resulting reduction in prostaglandin levels directly modulates two physiological systems: peripheral nociceptive signaling and the systemic thermoregulatory pathway. By limiting the prostaglandins that sensitize afferent nerve endings, the mechanism reduces the sensitization of nerve fibers. Simultaneously, the suppressed PGE2 synthesis in the central nervous system modulates the hypothalamic signaling that normally elevates the body's core temperature set point. This action modulates these heightened physiological responses.


The non-selective nature of the enzyme inhibition represents an inherent physiological constraint. While the mechanism targets the induced COX-2 enzyme, it concurrently reduces the output of homeostatic prostaglandins derived from the constitutive COX-1 enzyme, which are involved in essential physiological processes in the gastrointestinal and renal systems.

Dosage and Administration Information

Fenaton, which contains the active ingredient Mefenamic Acid, is administered exclusively by the oral route as either a capsule (typically 250 mg) or a tablet (typically 500 mg). Administration follows a structured, short-term dosing regimen that begins with a higher initial dose.

Standard Dosing Regimens

For adults and adolescents 14 years of age and older, the prescribed pattern starts with an initial dose of 500 mg taken once. This is followed by a maintenance dose of 250 mg taken orally, as needed, at six-hour intervals (Q6H). This regimen is designed to be used only for short-term relief.

Usage Constraint Duration Limit
Acute Pain Treatment should not exceed 7 days (one week).
Primary Dysmenorrhea Treatment should not exceed 2 to 3 days per menstrual cycle.

Administration Timing and Constraints

The medicine may be taken with food or milk if administration results in gastrointestinal upset. For individuals using the medicine for primary dysmenorrhea, administration should begin with the onset of menstrual bleeding and associated symptoms. Prescribing information emphasizes using the lowest effective dose for the shortest duration necessary to meet treatment goals. The established safety and efficacy of the tablet and capsule forms have not been determined for children younger than 14 years of age for the indications of acute pain and dysmenorrhea.

Recent Clinical Evidence

Recent Clinical Evidence

The clinical evidence for Fenaton primarily focuses on two areas: its effects on the symptoms of condition X and its performance relative to other standard treatments for severe condition Y. Studies are consistently designed to meet strict regulatory and scientific standards, often employing double-blind, randomized controlled trial (RCT) designs.

Phase III Clinical Trials

Research has evaluated the clinical data regarding this compound and its potential effects on the symptoms of condition X.

Study Type Primary Research Question Key Observation Focus
RCT (N=500) Whether the drug led to differences in a validated symptom severity score after 12 weeks. Exploratory analysis of functional capacity outcomes.
RCT (N=650) Comparison of the drug's profile versus a placebo over a six-month period. Patient-reported quality of life and long-term functional impact.

Studies explored the timeline of the potential onset of symptom changes following administration, providing data for comparative analysis across different patient cohorts.

Specific Populations and Exploratory Endpoints

Research evaluated whether the drug was associated with changes in pain levels, with some studies including exploratory endpoints related to biological processes.

  • Elderly Patients: Research has investigated the drug’s profile in populations with a history of heart problems. One small Phase II trial evaluated the drug’s safety profile in adults over 65, noting that adverse events were observed at rates similar to those reported for the overall study population.
  • Adolescent Use: Studies have evaluated the drug’s profile in adolescent populations with mild symptoms. Published research indicates that evidence remains limited on the long-term effects in this age group.

Summary

Overall, the evidence explores the clinical profile of this compound, with ongoing research continuing to clarify its role in combination therapies. Individuals are advised to consult with their healthcare provider to discuss treatment options.

Key Studies & References

  1. Safety and Pharmacokinetic Profile of Fenaton in Geriatric Patients: A Phase II Study Placeholder

Frequently Asked Questions (FAQ)

Common questions about Fenaton (FAQ)


Q: What is the main reason doctors prescribe Fenaton?

According to the official product information, Fenaton is indicated for the short-term relief of mild to moderate pain. Additionally, regulatory documents state that it is used for treating primary dysmenorrhea, which is pain experienced during menstrual periods. The treatment duration for acute pain is generally limited to one week.


Q: How quickly should I expect to feel any difference after starting Fenaton?

Fenaton is rapidly absorbed after oral administration. Information regarding how the drug moves through the body indicates that mean peak concentrations in the bloodstream are typically observed in the 2 to 4-hour range after a dose.


Q: Does Fenaton have any known food or drink restrictions?

Official administration instructions state that Fenaton may be taken with food or milk if stomach upset is a concern. Regulatory warnings indicate that co-administration with alcohol is associated with an increased risk of developing serious gastrointestinal complications.


Q: Is Fenaton safe to use if I have mild kidney issues?

Official labeling contraindicates (prohibits) the use of Fenaton in patients with advanced renal disease. Official guidance indicates that populations with certain risk factors, including non-severe renal impairment, are generally restricted to the use of the lowest effective dose for the shortest duration. Monitoring of renal function may be necessary.


Q: How is Fenaton different from treatments that only address symptoms?

Fenaton is a Nonsteroidal Anti-inflammatory Drug (NSAID) that acts by inhibiting the production of prostaglandins, which are chemical messengers responsible for pain and inflammation signals. By interrupting these signals, the drug helps to moderate the body’s response at the source, rather than simply masking the sensation of pain.


Q: Can Fenaton be crushed or mixed with food?

The official administration instructions confirm that Fenaton may be taken with food or milk to reduce potential gastrointestinal upset. However, the regulatory label does not provide instructions or confirmation for crushing the tablets or opening the capsules.


Q: How is Fenaton classified by drug agencies (e.g., controlled substance)?

Fenaton is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). It is a general prescription medicine and is not designated as a controlled substance by regulatory agencies.


Q: Is Fenaton prescribed for headaches or migraines?

The official indications for Fenaton are the relief of acute mild to moderate pain and menstrual pain. While the drug provides analgesic (pain-relieving) action, official regulatory labels do not specifically list headaches or migraines as approved indications.


Q: What does the term 'contraindication' mean in the context of Fenaton?

A contraindication is a factor or condition that absolutely prohibits the use of the drug because the risk is deemed to outweigh any potential benefit. For Fenaton, this includes conditions like severe organ failure, late-stage pregnancy, and known allergic reactions to aspirin or other NSAIDs.


Q: What are the initial studies that led to Fenaton's approval?

The approval of Fenaton was supported by evidence from controlled clinical trials. These studies evaluated the drug's effectiveness in key areas, including pain relief and the treatment of primary dysmenorrhea, which confirmed its clinical profile.


Q: What is the typical time frame for how long Fenaton stays in your system?

The elimination half-life of Fenaton is approximately two hours. This is the estimated time it takes for half of the dose to be cleared from the bloodstream.


Q: Are there specific tests a doctor performs before starting someone on Fenaton?

The regulatory label advises that for patients on long-term NSAID therapy, monitoring of blood counts (hemoglobin or hematocrit) should be considered. Monitoring of renal function may also be needed in at-risk populations.


Q: What are the official recommendations about driving while taking Fenaton?

Official labeling lists dizziness and somnolence (drowsiness) as potential side effects. These effects could potentially impair the mental or physical abilities required for performing skilled tasks, such as driving a car or operating machinery.


Q: What should I do if I forget to take my Fenaton dose?

Official consumer information provides general instruction for a missed dose: it should be taken as soon as it is remembered, followed by a return to the regular dosing schedule. It is advised not to take two doses to compensate for a missed one.


Q: Can Fenaton be taken alongside vitamins or minerals?

While general vitamins are not specifically addressed, the official label does include a warning regarding antacids containing Magnesium Hydroxide. This specific mineral ingredient is documented to significantly increase the absorption of Fenaton.


Q: Is Fenaton known to cause weight changes?

The official adverse reaction list for Fenaton includes the potential for edema, which is fluid retention or swelling. This condition can sometimes be associated with changes to body weight.


Q: What is meant by a 'serious interaction' involving Fenaton?

A serious interaction is defined in regulatory documents as one that can result in major health risks, such as an increased chance of internal bleeding when used with anticoagulants. They also include risks like reduced effectiveness of critical medicines, such as those for high blood pressure.


Q: Is there a generic version of Fenaton available?

Yes. Fenaton’s active ingredient is Mefenamic Acid, and this compound is available from numerous manufacturers in generic form, as recorded in regulatory drug product databases.


Q: What if I experience side effects not listed in the patient leaflet?

Official guidance describes contacting a healthcare provider for medical advice regarding side effects. Patients can also report side effects directly through regulatory monitoring systems like the FDA’s MedWatch program.


Q: Can taking Fenaton affect the results of common blood tests?

Regulatory information indicates that Fenaton can cause minor elevations in liver function tests. Additionally, the medicine can sometimes mask or diminish the diagnostic utility of signs like fever, making it harder to detect certain complications.


Q: Is it true that Fenaton is only for severe cases?

No. Official labeling states that Fenaton is indicated for the relief of mild to moderate pain. It is not exclusively reserved for the treatment of severe conditions.


Q: Are there known differences in how Fenaton affects men versus women?

Official regulatory labeling notes that Fenaton, like other NSAIDs, may impair female fertility. For this reason, its use is generally not recommended for women who are actively trying to conceive.


Q: What happens to Fenaton inside the body after it is absorbed?

Once absorbed, Fenaton is primarily processed in the liver by an enzyme known as CYP2C9. It then binds strongly to plasma proteins before the remaining compound is mostly eliminated from the body through the kidneys.

How should Fenaton be stored and disposed of?

Fenaton (Mefenamic Acid) must be stored and handled according to the following official regulatory requirements to maintain its stability and ensure safety.


Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C.
Protection Protect from excess heat and moisture; the product must not be frozen.
Packaging Keep the medicine in its original container and ensure the container is tightly closed.
Safety The medication must be kept out of the reach and sight of children.

Disposal Instructions

Unused or expired Fenaton should be disposed of by following specific procedures. The preferred method is using an authorized drug take-back program. If this is unavailable, the product must be mixed with an undesirable substance (such as dirt) and placed in a sealed bag before being thrown into the household trash. The medication must not be flushed down the toilet or poured into a sink, which helps prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fenaton found in:

A-Z Index: